Organisation mondiale de la santé (OMS) · Journal articles

Polio case in Darfur sparks fears of epidemic in west and central Africa.

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

557Bulletin of the World Health Organization | July 2004, 82 (7) WHO News G-8 endorses new global HIV vaccine enterprise The formation of a new global consor- tium to streamline research and develop- ment efforts to accelerate progress towards an HIV vaccine was announced by G-8 countries during their annual summit which took place in the US state of Georgia in June — an initiative wel- comed by WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS). The plan — endorsed by Canada, France, Germany, Italy, Japan, the Russian Federation, the UK and the US — calls for the establishment of HIV vac- cine development centres throughout the world, the expansion of manufacturing capabilities, the creation of standardized measurement systems, the construction of clinics for trials and the creation of rules allowing regulatory authorities in different countries to recognize the results of foreign clinical trials. “I welcome the G-8’s political en- dorsement of this initiative,” said WHO Director-General, Dr LEE Jong-wook. “The Global HIV Vaccine Enterprise will bring a new political and financial dimension to addressing the complex challenge of developing a safe and effec- tive HIV/AIDS vaccine.” According to WHO, HIV/AIDS vaccine development has been slow mainly due to “enormous” scientific, logistical and financial hurdles. Since the discovery of HIV as the cause of AIDS in 1983–84, numerous vaccine candi- dates have been tested in more than 70 human clinical trials but with moderate success. So far, only one vaccine candi- date has concluded the stage of definitive trials but it did not show any noticeable level of efficacy. The Global HIV Vaccine Enterprise aims to enhance coordination, informa- tion sharing and global collaboration amongst the world’s HIV vaccine researchers in industrialized and develop- ing countries in both private and public sectors. The initiative will prioritize the scientific challenges that need to be overcome, coordinate product develop- ment efforts and encourage greater use of information sharing technologies. According to WHO, this would mean that existing resources would be better aligned and could be channelled more efficiently. It is hoped that the plan will also encourage more effective syner- gies between research efforts and global preventative and therapeutic efforts. “AIDS has always challenged us to do business differently, and this is no less true with the development of a vaccine,” said UNAIDS Executive Director, Dr Peter Piot. “The G8’s endorsement of the Global HIV Vaccine Enterprise is a vital boost to help it forge the strategic planning, collaboration, and global investment of resources by governments and industry that is commensurate with the intensive effort required to develop a globally accessible and affordable HIV vaccine.” Partners in the enterprise include the National Institute of Allergy and Infec- tious Diseases Vaccine Research Centre in the US, the European Research Institutes, the International AIDS Vaccine Initia- tive, European Union and national HIV vaccine programmes and research institutions from developing countries. More information about the pro- gramme is available from the UNAIDS website: www.unaids.org O Polio case in Darfur sparks fears of epidemic in west and central Africa West and central Africa are on the verge of the largest polio epidemic in recent years, warned experts from the Global Polio Eradication Initiative. The warning followed a confirmation on 22 June that a child was paralysed on 20 May by po- lio in the Darfur region of the Republic of Sudan, a country which has not seen the disease for more than three years. “There is no question that the virus is spreading at an alarming pace,” said Dr David Heymann, WHO Repres entative for Polio Eradication. “The fact that the Sudan is now re-infected is concrete evidence of the need to sup- port a massive immunization response right across west and central Africa.” Epidemiologists said that the polio- virus in the Sudan shares close genetic links to the virus in northern Nigeria, which has spread through Chad in recent months. According to Heymann, the re-infection of the Sudan represents the latest setback to progress made towards achieving polio eradication in Africa. “At the beginning of 2003, only two countries in sub-Saharan Africa were polio-endemic. Today, however, Africa accounts for nearly 90% of the global polio burden, with children now paralysed in ten previously polio-free countries across the continent,” said Heymann. Children in west and central African countries will be particularly vulnerable during the polio “high season” this autumn when experts fear a major epidemic. Less than half of children in the region are routinely immunized against polio. Experts from the Global Polio Eradication Initiative, spearheaded by WHO, Rotary International, the US Centers for Disease Control and Preven- tion and the United Nations Children’s Fund (UNICEF), recommended synchronized immunization campaigns across 22 African countries in October and November 2004 to reach 74 million children. “These campaigns could avert a public health tragedy,” said Carol Bellamy, UNICEF Executive Director. “But to be effective they must have strong, grass- roots support. The first priority should be to increase community participa- tion in polio activities throughout the region.” The northern Nigerian state of Kano is the epicentre of the region’s outbreak, resulting in part from a local controversy over the safety of the polio vaccine which had led to the suspen- sion of immunization campaigns earlier in the year. Following an an- nouncement by Kano state authorities in May 2004, however, it is hoped that polio immunization activities in the state will soon recommence. Despite the statement, the local community still needs reassurance, said Bellamy. According to WHO, responding to this looming epidemic will require an additional US$ 100 million, of which US$ 25 million is urgently required by August for the first campaign. O 558 Bulletin of the World Health Organization | July 2004, 82 (7) WHO News Developing countries face safe blood shortage Stricter quality checks for blood transfu- sions and more blood donors are needed in developing countries, said experts from WHO on World Blood Donor Day on 14 June. Whilst celebrations took place in many cities around the world to mark the contributions made by voluntary blood donors everywhere, the overwhelming majority of the world’s population — 82% — does not have access to safe blood. Most of these live in regions with the heaviest burdens of disease where an adequate, safe supply of blood is in constant need. “A sufficient, safe blood supply is a key part of an effective health care system and essential for disease preven- tion,” said WHO Director-General, Dr LEE Jong-wook. “In our work to increase access to treatment for people living with AIDS around the world, safe blood is a crucial part of our pre- vention and care strategy.” Many developing countries still rely on blood from family replacement or paid donors and in these countries, the seroprevalence in donors for trans- fusion-transmissible infections such as HIV, hepatitis B and C, and syphilis, is much higher than in countries with voluntary, unpaid donation. An adequate supply of safe blood requires a pool of healthy, regular, volun- tary donors who give blood without financial or other reward. According to WHO, research has shown that donors who give blood voluntarily are the safest donors. However, a recent WHO survey shows that only 39 of 178 countries have 100% voluntary, unpaid blood dona- tion. The survey also showed that 20 countries in the world do not have 100% screening for HIV and 24 do not have 100% screening for hepatitis B, 37 for hepatitis C and 24 for syphilis. A number of countries do not screen at all for these infections. In spite of the poor figures, there are strategies in place to address the problem of blood safety in some countries such as South Africa and Zimbabwe. Zimbabwe’s Pledge 25 encourages school leavers to pledge to give blood 25 times before they are 25, while also committing to leading healthy lives in order to keep their blood safe. The initiative saw HIV infection rates among blood donors drop from 4.45% in 1989 to 0.61% in 2001. The shortage of safe blood is compounded by the shortage of donors in developing countries — where that blood is needed most. Of the estimated 81 million units of blood donated every year around the world, only 39% comes from developing countries, contributing to a global blood shortfall of around 40 million units a year. Despite efforts to rectify this imbalance, the average num- ber of blood donations has not improved significantly in developing countries — it remains around 12 times higher in industrialized countries than in devel- oped countries, according to WHO. Most countries still lack a nation- ally coordinated blood transfusion service and rely on voluntary blood donor organizations which have been set up in over 50 countries. Accord- ing to Daniela Bagozzi from WHO’s department of Health Technology and Pharmaceuticals, these organizations play a key role in blood donor recruit- ment and retention through peer education and promotion. O Unhealthy environments a major threat to young children The first-ever Atlas of Children’s Health, published by WHO on 22 June, attri- butes the annual deaths of more than three million children under the age of five to environment-related hazards such as unsafe water and sanitation, indoor and outdoor air pollution and climate change. Whilst only 10% of the world’s population is under five years old, 40% of the environment-related disease bur- den falls on children in this age group. The illustrated Atlas of children’s environmental health and the environment, launched during the Fourth European Conference of Health and Environment Ministers in Budapest, Hungary, aims to illustrate the impact of the environ- ment on children’s health. According to the Atlas, diarrhoea which is often caused by unclean water, kills an estimated 1.8 million people worldwide every year, 1.6 million of whom are children under the age of five. “Children are the main sufferers of environmental hazards. It is unac- ceptable from every point of view that the most vulnerable members of a society should be the ones who pay the price for failures to protect health from environmental dangers,” said WHO Director-General, Dr LEE Jong-wook, during the launch. It is hoped that the facts contained in the publication will draw attention to the urgent need for a more effective response to the United Nations Mil- lennium Declaration which calls on governments to reduce by two-thirds the under-five mortality rate by 2015. “This is a wake-up call for us and for the world,” said Dr Kerstin Leitner, WHO Assistant Director-General for Sustainable Development and Healthy Environments. “The number of child deaths is alarming. It paints a dismal picture of neglect. We must face up to reality and act now to work towards a sustainable and brighter future.” The Ganges River in India was highlighted as a major environmental hazard — 1.1 million litres of raw sew- age are dumped into it every minute. This represents a significant risk in the light of the fact that one gram of faeces in untreated water may contain 10 mil- lion viruses, one million bacteria, 1000 parasite cysts and a hundred worm eggs, according to WHO. In Asia, 65% of all wastewater is discharged untreated into rivers, lakes and oceans. Other major environmental hazards included the black smoke produced by cooking with solid fuels such as wood, dung, coal or crop waste — a method used by over 75% of households in most Asian and African countries. This puts children and others at risk of respiratory infections and may worsen pre-existing health problems such as pneumonia. O Bulletin board: have your say Readers now have the opportunity to comment on recently published articles that have appeared in the Bulletin, in the form of an informal letter to the editor. These comments will then be published on the Bulletin’s web site, after quick editorial review, under our new “Bulletin board” section and a selection will be chosen to appear in the print version of the journal. Please visit our web site at http://www.who.int/bulletin/en/ to access the latest articles and email your contributions to: bulletin@who.int.

Informations clés
Type de document Journal articles
Date d'adoption
Source Organisation mondiale de la santé